Skip to content
Doseworth

Provider review

SkinnyRx review: "From $199" is a year up front, and month two is $349

Every product on SkinnyRx reads "From $199 / month", and every one is a twelve-month prepay rate. Its own pricing module records the renewal separately: $349 for semaglutide, $399 for tirzepatide. Buy one month and stop and you pay $150 above the number that brought you here. SkinnyRx also holds an open FDA letter from February 2026, though it has removed all three claims cited in it.

By Marla Whitfield, Pricing Editor

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

The money verdict

I would buy here only on the annual plan, because month two is 75% more than the card promises. What I would credit is that SkinnyRx actually fixed what FDA cited: all three claims are gone, and the disclosure the letter said was missing is now on its pages.

Worth it if

  • You’re committing to a full year, because $199 a month for semaglutide is the twelve-month rate and nothing else.
  • You want every tier in front of you before you start — four terms per product, each with the term attached.
  • You pay for medication with an FSA or HSA card.
  • You’d rather swallow a tablet than inject, and identical pricing at every tier doesn’t put you off.

Look elsewhere if

  • You’re buying a month at a time: semaglutide is $349 and tirzepatide $399 from month two, 75% above the card.
  • You picked a microdose to spend less, because it renews at the full-dose price once the prepay term ends.
  • You want to read the February 2026 FDA warning letter first — it is open, with no close-out posted.
  • You want the pharmacy named before you order.
Cheapest — Compounded semaglutide

$349/mo

States served

SkinnyRx says only that "all our providers are based in the United States, where they are licensed and board certified." No state list, included set or excluded set is published on its site, and its FAQ doesn’t answer the question, so this review claims no coverage and asserts no exclusion

Billing cycle

Monthly (12×/yr)

At a glance

$229/mo

Advertised

the first-cycle rate

$349/mo

Walk-away

vs. advertised

$4,188

Year at this price

$349 × 12

The same Compounded semaglutide price, three ways

The short bar is the number SkinnyRx leads with. It lasts one cycle.

Advertised

first cycle only

$229

Walk-away

every cycle after

$349

Ready to check SkinnyRx’s current price?

Prices may change.

Best for: You’re committing to a full year, because $199 a month for semaglutide is the twelve-month rate and nothing else. Skip it if: You’re buying a month at a time: semaglutide is $349 and tirzepatide $399 from month two, 75% above the card.

Visit SkinnyRx

What’s included

  • Licensed provider review, with the provider deciding whether treatment is appropriate
  • Fulfillment stated as "pharmacy pickup or direct delivery where available"
  • In-app support from a care team, stated as continuing after the first order
  • "Cancel anytime", printed on the product pages
  • FSA/HSA cards accepted, per its own FAQ
  • Not included: any medication price for the two products sold through its $49 membership

Pricing, per compound

Everything SkinnyRx sells, cheapest year first. “Advertised” is the price it leads with; “Walk-away” is what you pay if you stop after one cycle.

ProviderAdvertisedWalk-awayYear at this price
Compounded semaglutide — microdose, weekly injection

A three-rung ladder rather than four: 8 months at $229, 4 at $299, 1 at $349, and a renewal rate of $349. The microdose renews at exactly the same price as the standard dose, so the saving exists only while the prepay term runs.

$229.00/mo$349.00/mo$4,188.00

$349.00 × 12 months

Compounded semaglutide — weekly injection

SkinnyRx's own price module carries the full ladder — 12 months at $199, 6 at $249, 4 at $299, 1 at $349 — and a separate renewal rate of $349 recorded for this product. The $349 is therefore both the one-month rate and the rate SkinnyRx's code says a subscription renews at, which is why it’s the walk-away figure rather than the $199 on the card.

$199.00/mo$349.00/mo$4,188.00

$349.00 × 12 months

Compounded tirzepatide — microdose, weekly injection

8 months at $319, 4 at $349, 1 at $399, and a renewal price of $399 — again identical to the full-dose renewal rate.

$319.00/mo$399.00/mo$4,788.00

$399.00 × 12 months

Compounded tirzepatide — once-daily tablet

The oral form, priced identically to the injection at every tier: 12 months at $299, 6 at $329, 3 at $349, 1 at $399.

$299.00/mo$399.00/mo$4,788.00

$399.00 × 12 months

Compounded tirzepatide — weekly injection

12 months at $299, 6 at $329, 4 at $349, 1 at $399, and a renewal rate of $399 recorded in the same module. The spread between the advertised and the renewal rate is $100 here against $150 on semaglutide — the tirzepatide card is the more honest of the two.

$299.00/mo$399.00/mo$4,788.00

$399.00 × 12 months

The year at this dose — 12 payments, or 13 where a seller bills every four weeks. Several charge more as you move to a higher dose; where they publish that, the row says so.

Every figure above was read on skinnyrx.com, one product at a time. Check the current price before you buy.

See SkinnyRx’s prices

How this compares

Pros and cons

Pros

  • "Cancel anytime" is on the cards, and no separate consultation fee is added to any medication price.
  • All three claims FDA cited in February 2026 have been removed, each returning zero occurrences across the homepage, how-it-works page and FAQ.
  • The full price ladder exists in one place and is internally consistent — four tiers per product, each with the term attached.
  • It prints the compounded-drugs disclosure on its own pages — the exact one the FDA letter says it was missing.
  • It states its compounding category outright (503A) rather than leaving the pharmacy type unsaid.
  • Microdose versions of both molecules are sold as their own products with their own ladders, rather than as an undisclosed dose reduction.
1 more
  • It records what a plan renews at rather than leaving you to find out, and that figure matches its own one-month tier exactly.

Cons

  • Every advertised price is a twelve-month prepay rate: "From $199 / month" renews at $349, so month two costs 75% more than the card.
  • The microdose products renew at the same price as the full-dose ones, which means the lower rate lasts only as long as the prepay term.
  • A year month to month is $4,188 for semaglutide and $4,788 for tirzepatide, against $2,388 and $3,588 on the twelve-month rate.
  • No dispensing pharmacy is named anywhere, and the FAQ answers "Are your pharmacies FDA-compliant?" about 503A pharmacies in general rather than its own.
  • Two products are sold "via SkinnyRx Membership" at $49 a month with no medication price published for either.
  • It holds an open FDA warning letter, issued to Lean Rx, Inc. on February 20, 2026, with no close-out letter posted.
2 more
  • "FDA-compliant" is not what a 503A pharmacy is — compounded preparations are exempt from FDA approval rather than compliant with it.
  • The daily tablet costs exactly the same as the weekly injection at every tier, so the oral form carries no price advantage over the form the trials tested.

Where else SkinnyRx appears

Boards this company appears on

Compare the cost of compounded semaglutide · Compare the cost of compounded tirzepatide

How we verified this

What we checked

  • Every price read off skinnyrx.com — 5 products, checked one at a time
  • The billing cycle taken from the company's own terms, not assumed from the price
  • States, inclusions and cancellation terms read on the company's own pages
  • Screened against the FDA's live warning-letter index

What to double-check before you buy

  • Compounded tirzepatide: Worth knowing before choosing on convenience — SkinnyRx charges the same for a daily tablet as for the weekly injection the trials actually tested.
  • Prices may change. Confirm before you buy.

Key terms

Show definitions
Walk-away price
What one cycle costs at the ongoing rate with no commitment — what you actually pay if you stop after month one.
Year at this price
The walk-away price multiplied by however many times a year it's actually billed. It's the year at this dose only — several sellers charge more as you move up, and most don't publish the ladder.
Compounded
Made to order by a pharmacy from raw ingredients, rather than dispensed as an FDA-approved, mass-manufactured product.

Bottom line

Budget $349, not $199, unless you are prepaying a year. The microdose products are the trap inside the trap — they renew at the full-dose price, so the cheaper rate lasts exactly as long as your prepay term.

Visit SkinnyRx

Frequently asked questions

What does SkinnyRx actually cost?

If you pay for one month and stop: $349 for compounded injectable semaglutide and $399 for injectable tirzepatide, with the tirzepatide tablet also at $399. The advertised "From $199" and "From $299" are the twelve-month prepay tiers. In between sit $249 and $299 for semaglutide at six and four months, and $329 and $349 for tirzepatide at six and four. These come from SkinnyRx's own pricing module rather than from a percentage worked backwards off a badge.

Why is the price on the card so different from the price in month two?

Because the card quotes the longest commitment. SkinnyRx's price module stores four tiers per product and records the renewal rate separately — $349 for semaglutide, $399 for tirzepatide. Those renewal figures match the one-month tier exactly, which is the clearest signal a seller can give about what happens when a prepay term ends: you go back to the one-month rate. The $150 gap on semaglutide is the widest on this review.

Has SkinnyRx had an FDA warning letter?

Yes, and it’s open. FDA issued it to Lean Rx, Inc. dba SkinnyRx on February 20, 2026 (MARCS-CMS 717989, posted March 3) after reviewing skinnyrx.com in December 2025. It cited three claims — including "the same active ingredient as name-brand GLP-1 medications" — as false or misleading, on the grounds that they imply a compounded drug has been FDA-approved when it hasn’t. It alleges nothing about sterility, potency or product quality, and no close-out letter has been posted. What is also true: all three cited claims are gone from the site as of August 11, 2026, and the disclosure FDA said was missing now appears on its pages.

Is the daily tablet cheaper than the injection?

No. SkinnyRx prices compounded tirzepatide tablets identically to the injection at every tier — $299 at twelve months, $329 at six, $349 at three or four, $399 at one. That’s worth knowing because the tablet's appeal is convenience rather than cost, and because the trials behind tirzepatide tested a weekly subcutaneous injection rather than a daily oral dose.

Which pharmacy fills a SkinnyRx prescription?

It doesn’t say. Its FAQ asks "Are your pharmacies FDA-compliant?" and answers "Yes. 503A pharmacies are licensed by state boards of pharmacy and are FDA-compliant" — a statement about the category, not about its own pharmacies, with no name, state or license number given. The phrase is also loose: a 503A pharmacy's preparations are exempt from FDA approval rather than compliant with it, so "FDA-compliant" describes a status that doesn’t exist for compounded drugs.

Sources

Every price above was checked against SkinnyRx’s own pricing page — never a third-party aggregator:

Show every source link

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.